ARCHIVES

NCAB Meeting Moved To October

This article is from The Cancer Letter archive.

Vol. 05 No. 29 | July 20, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Obama Picks Daschle for HHS Secretary. Waxman Gains Chairmanship of Energy & Commerce.

November 21, 2008